Deepwater PFAS Contamination: The Chemours Settlement Does Not Compensate You — Your Private Legal Rights in Salem County, New Jersey
You saw the news: Chemours agreed to pay a $22.5 million civil penalty and spend $90 million to control PFAS discharges at Chambers Works in Deepwater. Maybe you felt relief. Maybe you thought the government is finally handling this, and your family is taken care of. That feeling is understandable. It is also the most dangerous thing you could believe right now, because it is not true.
The consent decree between Chemours and the federal government resolves regulatory violations — broken permits, unauthorized discharges, pollution of the Delaware River. It does not pay a single dollar to you for the water your family drank. It does not cover your medical monitoring, your kidney cancer treatment, your child’s developmental delays, or the value your property lost when the world learned what was in your tap water. It does not compensate a single resident of Pennsville Township for a single day of exposure. Those rights — your private legal rights to compensation for what was done to you — are fully intact, separate from the government’s settlement, and they are running on a clock that most people in Salem County do not even know has started.
We are Attorney911. We are a trial firm that takes New Jersey environmental contamination and toxic exposure cases, and we are writing this for one person: you, sitting at a kitchen table in Deepwater or Pennsville or Carneys Point, wondering whether the water that came out of your faucet for the last twenty years is the reason someone in your family got sick. The answer to that question is medical, legal, and urgent — and the government’s settlement with Chemours is the beginning of that answer, not the end of it.
What Happened at Chambers Works: A Century of Chemical Manufacturing and Decades of PFAS Discharge
Chambers Works sits on roughly 1,455 acres along the Delaware River in Deepwater, Pennsville Township, Salem County — about 35 miles south of Philadelphia. Built in the late 1880s, it has been a hub of chemical manufacturing for more than a century. It is where DuPont accidentally discovered Teflon — the oldest chemical in the PFAS family, the family now called “forever chemicals” because they do not naturally break down. They accumulate in the human body, in the water, in the soil. They persist for generations.
In 2015, DuPont spun off its performance chemicals business into a new company called The Chemours Company. Chemours, headquartered in Wilmington, Delaware, with a market capitalization of approximately $2.73 billion, took over operations at Chambers Works. But the contamination did not start in 2015. It started decades earlier — under DuPont’s watch — and it continued.
Court filings in the proposed consent decree document what the government found: surface water discharged from the plant in 2003, 2005, and continuously from 2007 through 2020 “consistently detected PFOA and PFOS” — two of the most common and most studied PFAS compounds. Chemours “frequently released unauthorized discharges” over the past decade, in violation of federal water permits. The proposed settlement, filed in federal court in West Virginia and covering sites in New Jersey, North Carolina, and West Virginia, states the consequence in the government’s own words:
Managers at the three sites “have released, and continue to release, significant quantities of PFAS into the environment” and these discharges “have affected the drinking water of tens of thousands of people in the areas nearby.”
Tens of thousands of people. In Salem County, where communities rely on a mix of municipal water systems and private wells, where the Delaware River carries contaminants with its tidal flow patterns miles downstream, where the river is a drinking water source for communities across three states — the exposure radius extends well beyond the plant’s fence line. The Delaware River Basin Commission regulates water quality in the region, and the river’s tidal nature means contaminants can travel significant distances from the discharge point, expanding the potential exposure zone far beyond the immediate vicinity of Chambers Works.
This is not a new story for Salem County. New Jersey previously secured a $2 billion settlement with DuPont over pollution at this same site. The state separately secured a $450 million settlement with 3M for related PFAS contamination at Chambers Works — because 3M was the company that manufactured and supplied the PFAS chemicals DuPont used on site. Those settlements, like the current Chemours consent decree, addressed environmental remediation and regulatory violations. They did not compensate individual residents for personal injuries. That work — the work of holding these companies accountable to the people they exposed — is what private toxic tort litigation does, and it is a separate fight from the one the government just finished.
The Consent Decree: What the Government Settlement Covers — and What It Leaves Unresolved for Private Claims
The proposed consent decree, which is open to public comment through July 29, 2026, and requires judicial approval before it becomes effective, does three things. First, it imposes a $22.5 million civil penalty on Chemours, payable in annual installments over three years, for alleged violations of federal pollution and water laws. Second, it requires Chemours to conduct a $90 million program to limit the discharge of PFAS from its plants. Third, it requires the company to test drinking water and provide a treated or clean water supply to affected residents.
What it does not do is pay you for what happened to your body.
A consent decree is a settlement between the government and a company. It resolves the government’s enforcement claims — the regulatory violations, the permit breaches, the pollution of public water. It is not a class action settlement. It does not create a claims process for injured individuals. It does not pay medical bills. It does not compensate for pain and suffering, for lost wages, for diminished property values, for the anxiety of learning you have been drinking contaminated water for decades, or for the cost of medical monitoring that exposed residents now need for the rest of their lives. It does not pay families who lost someone to kidney cancer, liver disease, or a blood disorder that may be connected to years of PFAS exposure.
Whether the consent decree includes any release of private tort claims — whether it attempts to preclude individual residents from suing Chemours, DuPont, or 3M for personal injuries — is a legal question that must be examined carefully by qualified counsel before any resident assumes their rights have been affected. In our experience, government environmental settlements typically address regulatory and remediation obligations, not private tort claims, but every consent decree is different and the specific release language must be reviewed. What we can tell you with certainty is this: the existence of the government settlement does not mean your private legal rights have been resolved. They have not been. You still have them. The question is whether you will exercise them before the clock runs out.
One critical thing to understand about the consent decree: it is, in effect, a powerful admission. The company has agreed to pay penalties and spend $90 million on discharge controls because the government documented that it violated federal water permits and released unauthorized PFAS discharges for more than a decade. In private litigation, that documented pattern of violations becomes evidence — evidence that the company knew it was discharging PFAS, evidence that it knew those discharges exceeded what its permits allowed, and evidence that it continued anyway. The consent decree does not need to be a release to be valuable to your case. It is valuable because it is the government’s own record of what the company did.
The Defendant Stack: Chemours, DuPont, 3M, and the Corporate Shell Game
A PFAS contamination case at Chambers Works is not a case against one company. It is a case against a stack of corporate defendants, each responsible for a different piece of the contamination, each with its own insurance and balance sheet, and each designed — through corporate structure — to make it harder for you to reach the entity with the money.
The Chemours Company is the current operator. It took over Chambers Works in the 2015 spin-off from DuPont. Under the consent decree, it is responsible for PFAS discharges documented from 2015 through 2020 and for unauthorized discharges over the past decade. With a market capitalization of approximately $2.73 billion, Chemours is a deep-pocket defendant. But its lawyers will argue that it inherited a problem DuPont created, and that its liability should be limited to the post-2015 period.
DuPont — E.I. du Pont de Nemours and Company and its corporate successors — is the historical operator. DuPont ran Chambers Works from the 1880s through the 2015 spin-off. It is responsible for the original PFAS contamination and for the decades of documented discharges that the government sampled from 2003 through 2020. DuPont previously settled with New Jersey for $2 billion over pollution at this site — a figure that tells you both the severity of the contamination and the financial depth available to private plaintiffs. The 2015 spin-off was a corporate restructuring that may complicate — but does not eliminate — DuPont’s liability for contamination that occurred on its watch.
3M Company manufactured and supplied the PFAS chemical compounds that DuPont used at Chambers Works. 3M previously settled with New Jersey for $450 million for related contamination at this site. 3M had its own internal knowledge of PFAS health risks — knowledge that predated the public’s awareness by years or decades. Product liability claims against 3M include design defect (manufacturing and supplying an unreasonably dangerous product), failure to warn (not adequately warning users and the public of known health risks), and supplying a product whose risks outweighed its utility.
Waste management contractors and haulers are discovery targets — entities involved in the transport, disposal, or treatment of PFAS-containing waste streams from Chambers Works. They may share liability for off-site contamination through contribution and migration pathways. Their role emerges through discovery, not from the headline.
The corporate shell game in PFAS cases follows a predictable pattern: Chemours points at DuPont and says “they started it.” DuPont points at the spin-off and says “that was the old company.” 3M points at DuPont and says “we just supplied the chemicals — they decided how to use and discharge them.” Each defendant tries to shrink its share of liability by expanding someone else’s. New Jersey law has an answer for this: the Spill Act imposes strict, joint-and-several liability, which means any one defendant can be held responsible for the entire harm — and the defendants can sort out contribution among themselves. The corporate structure is not a shield. It is a map of who to sue.
New Jersey Law: Your Rights Under the Spill Act, Negligence, and Medical Monitoring
New Jersey maintains one of the most robust environmental tort frameworks in the country. If you were exposed to PFAS-contaminated drinking water from Chambers Works, several legal theories may apply to your case — and each one gives you a different path to compensation.
The New Jersey Spill Compensation and Control Act is the anchor. The Spill Act imposes strict, joint-and-several liability on any party that discharges a hazardous substance into the environment. PFAS compounds are regulated as hazardous substances under New Jersey law. Strict liability means you do not have to prove the company was careless — you have to prove it discharged a hazardous substance and that the substance caused your harm. Joint-and-several liability means that if multiple defendants contributed to the contamination, you can recover the full amount from any one of them, and they sort out the shares among themselves. The consent decree documents unauthorized discharges over more than a decade — that is your liability evidence, sitting in a government filing.
Negligence is the second theory. Chemours and DuPont failed to exercise reasonable care in preventing, monitoring, and controlling PFAS discharges despite growing scientific knowledge of health risks. They continued unauthorized discharges in violation of federal water permits from 2003 through 2020. The question is not whether they knew PFAS was in the water — the government’s own sampling proved that. The question is what they did about it, and the consent decree’s documentation of “frequent unauthorized discharges” over a decade suggests the answer is: not enough.
Negligence per se turns their regulatory violations into civil liability. When a company violates a statute or regulation designed to protect a class of people (here, residents who drink the water) from the type of harm that occurred (contamination of drinking water with toxic substances), that violation can be treated as negligence in itself. The Clean Water Act makes it illegal to discharge pollutants into navigable waters without a permit. The NPDES permit program sets enforceable effluent limits. The consent decree documents that Chemours “frequently released unauthorized discharges” in violation of federal water permits. New Jersey also maintains its own PFAS drinking water standards through NJDEP — standards that are independent of and stricter than the federal EPA limits. Even as the current federal administration works to unwind the EPA’s 2024 PFAS drinking water regulations, New Jersey’s state-level standards remain in force and provide an independent regulatory basis for negligence per se claims.
In 2024, the EPA established the first-ever National Primary Drinking Water Regulations for PFAS, setting enforceable limits for PFOA and PFOS at 4.0 parts per trillion — a number so vanishingly small it is roughly equivalent to a single drop spread across twenty Olympic swimming pools. The EPA set the Maximum Contaminant Level Goal — the level at which there is no known health risk — at zero. Zero. The federal government’s own regulators concluded there is no amount of these chemicals in drinking water that they consider safe. That regulatory finding is a standard-of-care anchor: the companies that discharged PFOA and PFOS into the Delaware River were releasing substances that the government has now determined have no safe exposure threshold.
Public nuisance covers the contamination of the drinking water supply affecting tens of thousands of nearby residents. The consent decree itself states the discharges “have affected the drinking water of tens of thousands of people.” That is an unreasonable interference with a public right — access to safe drinking water — and the defendants controlled the instrumentality causing the harm.
Private nuisance and trespass apply when PFAS migrated onto your private property and into your private well. PFAS that traveled from Chambers Works through groundwater or river water onto your land and into your drinking water supply is a physical invasion of your property by toxic substances. That is trespass. The interference with your use and enjoyment of your property — the inability to safely drink your own well water — is private nuisance.
Medical monitoring is a remedy New Jersey courts have recognized in toxic exposure litigation. It allows exposed residents to recover the costs of ongoing medical surveillance even without a present manifestation of disease. This is critical for PFAS cases because PFAS-associated diseases — kidney cancer, liver damage, blood disorders, immune system effects — can take years or decades to manifest after exposure. Medical monitoring means you do not have to wait until you are sick to recover. You can recover the cost of the periodic screening you need because a company contaminated your water: kidney function tests, liver panels, blood counts, cholesterol monitoring, thyroid screening, developmental surveillance for children. For tens of thousands of exposed residents, this is the most immediately relevant form of compensation.
Product liability claims against 3M run on a separate track. 3M manufactured and supplied the PFAS chemicals used at Chambers Works. Strict product liability attaches to the supplier of an injury-causing chemical: claims include design defect (the product was unreasonably dangerous), failure to warn (3M knew of PFAS health risks and did not adequately warn), and manufacturing defect. 3M had internal knowledge of PFAS health risks that it did not disclose to DuPont, to regulators, or to the public for years. That concealed knowledge is the spine of both the product liability claim and the argument for punitive damages.
Strict liability for abnormally dangerous activities may apply to chemical manufacturing involving persistent, bioaccumulative, toxic substances that cannot be safely discharged. When a company’s activity is so dangerous that no amount of care can eliminate the risk, the law imposes liability regardless of the level of care exercised. Manufacturing and discharging “forever chemicals” that do not break down, that accumulate in human bodies, and that the government has now determined have no safe exposure level may meet that standard.
The statute of limitations. New Jersey’s personal injury statute of limitations is generally two years. But PFAS exposure is a latent injury — the disease can manifest years or decades after the exposure. New Jersey applies the discovery rule, which means the clock may not start ticking until you knew or reasonably should have known that you were injured and that your injury was caused by the exposure. For many Salem County residents, the connection between their drinking water and their health may only become apparent now — with the news of the Chemours settlement and the government’s documentation of decades of contamination. The discovery rule is why a prompt legal evaluation is critical, even for residents who are not yet symptomatic. But the discovery rule is not a guarantee, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. An attorney in your state must check the specific deadline that applies to your situation.
Punitive damages. New Jersey does not impose a statutory cap on punitive damages in environmental tort cases. The consent decree documents consistent PFOA and PFOS detection from 2003 through 2020 and frequent permit violations over the past decade. That pattern — decades of documented unauthorized discharges despite growing scientific knowledge of health risks — is exactly the kind of knowing, reckless conduct that punitive damages are designed to punish. The prior $2 billion settlement with DuPont and $450 million settlement with 3M for related contamination at this same site establish both the severity of the harm and the deep-pocket collectibility available to private plaintiffs.
Survival and wrongful death claims may apply for Salem County residents who succumbed to PFAS-associated diseases. If a family member died from kidney cancer, liver disease, or another condition potentially linked to PFAS exposure, the estate may have a survival claim for the decedent’s pain and suffering and medical expenses, and the family may have a wrongful death claim for the financial and relational losses they suffered. These claims have their own procedural requirements and deadlines, and they require prompt evaluation by toxic tort counsel.
PFAS Health Effects: What the Science Says and What to Watch For
PFAS — per- and polyfluoroalkyl substances — are called “forever chemicals” for a reason. They do not naturally disintegrate. They are persistent in the environment, bioaccumulative in the human body, and they have long human half-lives measured in years, not days. Once they enter your body through contaminated drinking water, they bind to serum proteins and concentrate in the liver and kidneys. They are not metabolized. They are not excreted quickly. They stay.
The science connecting PFAS exposure to human disease has been building for years. The C8 Science Panel — an independent panel of epidemiologists established as part of a class action settlement involving DuPont’s Washington Works plant in West Virginia — found “probable links” between PFOA exposure and six conditions: kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis. The International Agency for Research on Cancer — the world’s leading cancer science body — classified PFOA as Group 1, carcinogenic to humans, based on sufficient evidence in animals and strong mechanistic evidence. PFOS was classified as Group 2B, possibly carcinogenic. These classifications are hazard identifications — they mean the science has established that these chemicals can cause cancer in humans. They do not, by themselves, prove that your specific cancer was caused by your specific exposure. That bridge — specific causation — is what a toxic tort case builds with dose reconstruction, exposure modeling, and medical evidence.
The health effects documented in the scientific literature and recognized by government agencies include:
- Kidney cancer — the cancer with the strongest PFAS association, particularly renal cell carcinoma
- Testicular cancer — linked to PFOA exposure in the C8 Science Panel findings
- Liver damage — including elevated liver enzymes, non-alcoholic fatty liver disease, and liver enlargement
- Blood disorders — including elevated cholesterol, changes in liver enzyme levels, and effects on blood cell production
- Thyroid disease — disruption of thyroid hormone production and function
- Developmental delays in children — including effects on growth, learning, and behavior
- Immune system suppression — reduced antibody response to vaccines, increased susceptibility to infection
- Pregnancy-induced hypertension — elevated blood pressure during pregnancy
- Ulcerative colitis — a form of inflammatory bowel disease
The proof problem in every PFAS case is that these conditions have multiple causes. Kidney cancer occurs in people who were never exposed to PFAS. High cholesterol is common. Thyroid disease is widespread. The defense will argue that your condition was caused by something else — diet, genetics, age, lifestyle. The answer is dose reconstruction: establishing how much PFAS you were exposed to, for how long, through what pathway, and then connecting that exposure dose to the disease using the scientific literature and expert testimony. That work is why you need a law firm that knows how to build a toxic tort case — not just file a complaint, but construct the scientific bridge between the contamination in your water and the disease in your body.
For families watching a loved one who was exposed, here is what the science means in practical terms: if you lived near Chambers Works and drank water from a municipal system or private well drawing from the Delaware River or connected groundwater, and you or a family member has been diagnosed with kidney cancer, testicular cancer, liver disease, a blood disorder, thyroid disease, or a developmental condition in a child, the connection between the exposure and the disease is something a qualified physician and a qualified attorney should evaluate together. You do not have to be certain it was the water. You have to be willing to ask the question — and the earlier you ask it, the stronger the answer can be.
The Evidence Clock: What Records Exist, Who Holds Them, and How Fast They Can Disappear
Every toxic tort case is a race against the destruction of evidence. The contamination at Chambers Works spans decades, and the proof of what the companies knew, what they discharged, and when they knew it is scattered across government files, corporate archives, and laboratory databases — some of it stable, some of it on a clock that is already running.
Government-held records are relatively stable. EPA and NJDEP sampling data, NPDES permit records, violation notices, and compliance correspondence are maintained by government agencies and generally survive for extended periods. The surface water sampling results from 2003 through 2020 that documented consistent PFOA and PFOS detection are in government files. These are the backbone of the liability case, and they are not going anywhere. But they are also not all of the story — they show what the government found. What the companies knew is a different set of records.
Corporate laboratory data and internal sampling records are at risk. Chemours and DuPont maintained their own environmental monitoring programs, laboratory analyses, and internal compliance reports. The 2015 spin-off creates a significant risk of document destruction, loss, or transfer — records that were DuPont’s may have been divided, archived, or discarded in the corporate restructuring. Under federal law, TSCA Section 8(a)(7) requires any person who manufactured or imported PFAS since January 1, 2011, to report uses, production volumes, disposal, exposures, and known hazards to the EPA. That reporting requirement means the companies were required to compile and retain PFAS production and hazard records going back more than a decade. But the compilation is only as good as the records that survived, and the 2015 spin-off is the kind of corporate event that creates gaps.
Internal corporate documents showing what DuPont and Chemours knew about PFAS health risks are the highest-priority targets. These include internal toxicity studies, risk assessments, executive communications, board-level presentations, and safety committee minutes — documents that establish scienter, the knowledge element for punitive damages. What did these companies know about the health risks of the chemicals they were discharging into the Delaware River, and when did they know it? Corporate document retention policies and the 2015 spin-off create significant risk that these records are being lost, destroyed, or rendered inaccessible with each passing month. The preservation letter — a formal demand that the company freeze and retain all relevant documents — is the first line of defense, and it should go out to both Chemours and DuPont immediately.
Employee and contractor testimony is aging. Plant operators, environmental compliance staff, waste contractors, and laboratory technicians who worked at Chambers Works during the 2003–2020 discharge period are the witnesses who can testify about discharge practices, knowledge of PFAS risks, operational decisions, and any minimization or concealment of contamination. These witnesses are aging, retiring, and passing away. The 2015 spin-off accelerated employee turnover and attrition. Every month that passes without depositions being scheduled is a month in which a key witness may become unavailable. The depositions of aging workers from the discharge period should be scheduled promptly.
Residential well water testing results and municipal water quality reports connect site discharges to individual exposure. Historical testing records in private hands — well water tests, municipal water quality reports, homeowner correspondence with water utilities — may be lost or discarded if not preserved. Current testing should be conducted promptly to establish baseline exposure and detect any ongoing contamination. If you have old water test results, water bills, or correspondence with your water utility, keep them. They are evidence.
Medical and health records of affected residents document specific injuries and establish baseline health status. Medical records are generally retained per HIPAA and state requirements, but early documentation of exposure history and the temporal relationship to contamination strengthens specific causation. If you or a family member has been diagnosed with a condition potentially linked to PFAS, obtaining and preserving the complete medical record — including the diagnostic timeline, pathology reports, and treatment history — is essential.
The preservation letter is the tool that freezes evidence. The day you call a lawyer is the day that letter goes out — to Chemours, to DuPont, to any waste contractors identified through preliminary investigation, and to any third-party laboratories that processed environmental samples. The letter orders them to preserve all relevant documents, data, samples, and communications. Once the letter is on file, the destruction of evidence becomes spoliation — and a court can impose sanctions, including an adverse-inference instruction telling the jury they may assume the lost records were as bad as the plaintiff says. The letter is not a formality. It is the first shot in the evidence war.
The Defense Playbook: What Chemours and DuPont Will Try — and How Each Move Is Countered
The defense in a PFAS contamination case follows a predictable script. Knowing the plays in advance is not just preparation — it is protection. Here are the moves you should expect, and the answer to each one.
Play 1: “The government settlement resolved everything.” The company will point to the consent decree and suggest that the matter is closed — that the $22.5 million penalty and the $90 million discharge program mean the issue has been handled. The counter is direct: the consent decree resolves regulatory violations between the government and the company. It does not release private tort claims. It does not compensate individuals. It does not create a claims process for injured residents. Your right to sue for personal injuries, medical monitoring, property damage, and wrongful death is a separate legal right, held by you, not by the government. Whether the consent decree’s specific language affects private claims in any way is a question that must be reviewed by qualified counsel — but the existence of the settlement does not, by itself, end your case.
Play 2: “You cannot prove our PFAS caused your specific cancer.” This is the specific causation defense, and it is the hardest hurdle in any toxic tort case. The company will argue that kidney cancer, thyroid disease, and high cholesterol have many causes, and that you cannot trace your condition to PFAS from Chambers Works rather than to diet, genetics, age, or background exposure. The counter is dose reconstruction: using water utility data, residence history, well water testing, and hydrogeological modeling to establish how much PFAS you were exposed to, for how long, through what pathway. Combined with the general causation science — the C8 Science Panel findings, the IARC classification, the EPA’s determination that there is no safe level — a qualified toxicologist and epidemiologist can build the bridge from your exposure to your disease. The defense is right that PFAS is ubiquitous. But there is a difference between background exposure and the elevated, sustained exposure that comes from drinking contaminated water for years.
Play 3: “Chemours was not responsible for pre-2015 discharges — that was DuPont.” The 2015 spin-off is the corporate shell game. Chemours will argue it inherited a problem it did not create. DuPont will argue the spin-off transferred liability to Chemours. The counter is the New Jersey Spill Act, which imposes strict, joint-and-several liability on any party that discharged a hazardous substance — regardless of when. Both companies can be named as defendants. Both can be held responsible for the full harm. The question of who pays what share is a contribution issue between the defendants, not a bar to your recovery. The spin-off was a corporate decision. It was not a liability eraser.
Play 4: “The statute of limitations has expired.” The company will argue that the contamination has been known for years and that the two-year clock has run. The counter is the discovery rule: for latent diseases that manifest years or decades after exposure, the clock does not start until you knew or reasonably should have known of the injury and its cause. For many Salem County residents, the connection between their drinking water and their health is only now becoming apparent — with the government’s documentation of decades of contamination and the public announcement of the consent decree. The discovery rule is the reason a prompt legal evaluation is critical, but it is also the reason many residents who think they are too late may still be squarely within their rights.
Play 5: “Your property damage is speculative.” The company will argue that you cannot prove your property value was diminished by the contamination. The counter is real estate appraisal methodology: comparing property values in the affected area to comparable properties outside the contamination zone, before and after the public disclosure of the contamination. The consent decree’s own statement that the discharges “affected the drinking water of tens of thousands of people” is evidence that the contamination is real, widespread, and public — all factors that diminish property values.
Play 6: The quick settlement offer. At some point, a representative of the company or its insurer may contact affected residents with an offer of compensation — often a modest amount, accompanied by a release that would extinguish all future claims. The offer may come with a deadline. It may sound generous compared to what you expected. It is not. A release signed now, before your full exposure is documented and before any latent disease has manifested, would prevent you from ever recovering for future medical conditions, future medical monitoring, or future property damage. Do not sign any release, do not accept any individual compensation offer, and do not provide a recorded statement to any company representative or insurance adjuster without consulting qualified toxic tort counsel first.
How a PFAS Case Is Actually Built: From Preservation Letter to Trial
Here is how a PFAS contamination case is actually built — not the marketing version, but the real work, in the order it happens.
Week one: The preservation letter goes out. The day you call, letters go to Chemours, DuPont, and any identified waste contractors ordering them to preserve all documents, data, samples, and communications related to PFAS production, discharge, monitoring, and health effects at Chambers Works. This freezes the evidence. From the moment the letter is received, the destruction of relevant records becomes spoliation, with consequences that can include adverse-inference instructions and sanctions.
Weeks one through four: Records demands and intake. We demand government records — EPA sampling data, NJDEP compliance files, NPDES permit records, violation notices — through Freedom of Information Act requests and New Jersey’s public records laws. We collect your residence history, water source information, medical records, and family health history. We identify the exposure pathway: where you lived, what you drank, for how long, and how the contamination from Chambers Works reached your tap.
Months one through three: Expert engagement. We retain a toxicologist for general causation — the science showing that PFAS exposure causes the specific disease categories at issue. We retain an epidemiologist for exposure-response analysis — the science showing how the dose you received relates to the risk of disease. We retain a hydrogeologist for groundwater modeling and plume migration — the science that traces the PFAS from Chambers Works through the Delaware River and connected groundwater to your specific water supply. And we retain a medical monitoring expert to design a cost-effective surveillance program tailored to the exposure profile of Salem County residents.
Months three through six: Discovery and depositions. The defendants produce corporate documents — internal emails, memos, safety studies, toxicological assessments, board-level communications. We depose the environmental compliance staff, the plant operators, the laboratory technicians, and the corporate decision-makers. The question we are asking through every deposition is the same: what did you know about the health risks of the chemicals you were discharging, and when did you know it? The consent decree’s documentation of “frequent unauthorized discharges” over a decade gives us the roadmap. The corporate documents give us the destination.
Months six through twelve: Bellwether selection and case-specific proof. In a mass tort involving tens of thousands of affected residents, the court may select bellwether cases — individual plaintiffs whose cases are prepared for trial first, to test the evidence and establish settlement value. Your individual case is prepared with its own specific causation proof: your exposure dose, your medical history, your diagnosis, your damages. The number at the end — the figure a jury hears or a settlement is built from — is constructed from all of it: the government’s sampling data, the corporate knowledge documents, the expert testimony, your medical records, and the life-care plan or economic loss analysis that translates your harm into dollars.
The prior $2 billion settlement with DuPont and $450 million settlement with 3M for related contamination at this same site are not just numbers. They are evidence of the seriousness of the contamination and a compelling settlement-value anchor. They tell you — and they tell the defendants — what this contamination is worth. Your case is part of that same contamination, from the same site, caused by the same companies. The value is not a guess. It is an arithmetic problem built from the evidence.
What a PFAS Case Is Worth: Medical Monitoring, Injury Compensation, and Punitive Damages
Honest case valuation in a PFAS contamination case depends entirely on the facts of the individual plaintiff — the duration and intensity of exposure, the specific disease or condition diagnosed, the strength of the specific causation proof, and the scope of releases in prior regulatory settlements. No lawyer can tell you what your case is worth without reviewing your medical records, your residence history, and your water source data. What we can tell you is the framework — the categories of damages and the ranges that apply.
Medical monitoring claims are the most broadly applicable. Every exposed resident who drank contaminated water from a source affected by Chambers Works discharges may need periodic medical surveillance — blood tests for PFAS serum levels, kidney function panels, liver enzyme tests, cholesterol screening, thyroid function tests, and developmental monitoring for children. The cost of this surveillance, projected across a lifetime, can run into the tens of thousands of dollars per person. For a class of tens of thousands of affected residents, the aggregate medical monitoring value can reach nine figures. Individual medical monitoring recoveries typically range in the six-figure area, depending on exposure duration and the complexity of the monitoring protocol.
Individual injury claims for residents with diagnosed PFAS-associated conditions are worth substantially more. A kidney cancer case — with medical expenses, lost wages, pain and suffering, and future care needs — can reach seven figures. A wrongful death claim for a family member who succumbed to a PFAS-associated disease can reach seven to eight figures, depending on the decedent’s age, earning capacity, and family circumstances. The wrongful death claim compensates the family for the financial support, companionship, and guidance the decedent would have provided.
Property damage claims cover diminished property values in the affected area, the cost of water filtration systems, and the loss of use of contaminated water supplies. These claims are typically valued through real estate appraisal methodology comparing affected properties to comparable unaffected properties.
Punitive damages are warranted by the documented pattern of conduct: consistent PFOA and PFOS detection from 2003 through 2020, frequent unauthorized discharges over the past decade in violation of federal water permits, and the companies’ growing scientific knowledge of PFAS health risks during the period of discharge. New Jersey does not cap punitive damages in environmental tort cases. The prior $2 billion DuPont settlement and $450 million 3M settlement for this same site establish the financial magnitude of the harm and the defendants’ ability to pay.
The aggregate value of a coordinated mass tort across tens of thousands of affected Salem County residents — combining medical monitoring, individual injury claims, property damage, and punitive damages — could reach nine figures, potentially into the hundreds of millions, given the documented decades of unauthorized discharges, the deep-pocket defendants, and the severity of the health effects. Individual claims range from six-figure medical monitoring recoveries to multi-million-dollar cancer and wrongful death cases.
Specific causation proof — the ability to trace an individual plaintiff’s disease to the Chambers Works contamination — and the scope of any releases in prior regulatory settlements are the primary factors that can reduce individual case values. These are the battlefields where the defense fights hardest, and where the quality of your legal representation matters most.
Your First Steps: What to Do Now to Protect Your Family’s Rights
If you live or lived near Chambers Works in Deepwater, Pennsville Township, or any community along the Delaware River whose drinking water may have been affected by PFAS discharges, here is what you should do — and what you should not do — right now.
Do document your exposure history. Write down where you have lived, when you lived there, and what your water source was — municipal system, private well, or both. Include the years you lived at each address. If you have old water bills, well water test results, or correspondence with your water utility, gather them. If you work or worked at Chambers Works, document your employment dates and job duties. This timeline is the foundation of your exposure proof.
Do gather your medical records. If you or a family member has been diagnosed with kidney cancer, testicular cancer, liver disease, a blood disorder, thyroid disease, or a developmental condition, obtain the complete medical record — including diagnostic reports, pathology reports, treatment history, and medication records. The temporal relationship between your exposure and your diagnosis is part of the causation proof.
Do seek baseline medical evaluation. If you have been exposed to PFAS-contaminated drinking water and have not had recent blood work, talk to your physician about a comprehensive metabolic panel, liver function tests, kidney function tests, thyroid screening, and a lipid panel. PFAS serum blood testing is available through specialized laboratories and can establish your current body burden of these chemicals. This is both medically prudent and legally valuable — it documents your exposure while the evidence is current.
Do not sign anything from Chemours, DuPont, 3M, or any of their representatives or insurers. If you receive a letter, a form, an offer of compensation, or a request for a statement from any party associated with the contamination, do not sign it, do not return it, and do not provide a recorded statement. Any document you sign may contain a release that extinguishes your right to sue. Any statement you give may be used to undermine your claim. Everything should go through qualified counsel first.
Do not assume the government settlement takes care of you. It does not. The consent decree addresses regulatory violations and environmental remediation. It does not compensate you for personal injuries, medical monitoring, or property damage. Your private legal rights are separate, fully intact, and running on a statute-of-limitations clock that you should have evaluated now — not after the public comment period closes, not after the court approves the decree, not after you see if your symptoms get worse.
Do contact qualified toxic tort counsel for a free consultation. The evaluation of a PFAS exposure case is complex — it requires analysis of your exposure pathway, your medical history, the regulatory record, and the legal theories that apply under New Jersey law. The consultation should be free. The firm should work on contingency — meaning you pay nothing unless you recover. And the conversation should be confidential, with no obligation to file a lawsuit just because you asked the question.
Frequently Asked Questions
Does the Chemours settlement compensate me for my injuries?
No. The $22.5 million civil penalty and $90 million discharge reduction program resolve regulatory violations between the federal government and Chemours. They do not pay individual residents for personal injuries, medical monitoring, property damage, or wrongful death. Your private legal rights to compensation are separate from the government settlement and remain fully intact. Whether the consent decree’s specific language affects private tort claims in any way is a legal question that must be reviewed by qualified counsel — but the settlement does not, by itself, compensate you.
How do I know if I was exposed to PFAS from Chambers Works?
If you live or lived in Deepwater, Pennsville Township, or a community along the Delaware River near Salem County, and your drinking water came from a municipal system or private well drawing from the Delaware River or connected groundwater, you may have been exposed. The consent decree states the discharges “affected the drinking water of tens of thousands of people in the areas nearby.” PFAS serum blood testing is available through specialized laboratories and can measure your current body burden of these chemicals. A hydrogeologist can model whether your specific water source was in the contamination pathway.
What health conditions are linked to PFAS exposure?
The scientific literature links PFAS exposure to kidney cancer, testicular cancer, liver damage, blood disorders (including elevated cholesterol), thyroid disease, developmental delays in children, immune system suppression, pregnancy-induced hypertension, and ulcerative colitis. The C8 Science Panel found “probable links” between PFOA and these conditions. The International Agency for Research on Cancer classified PFOA as Group 1 (carcinogenic to humans) and PFOS as Group 2B (possibly carcinogenic). Not everyone exposed to PFAS will develop these conditions — but if you have been exposed and you have one of these diagnoses, the connection should be evaluated.
How long do I have to file a lawsuit in New Jersey?
New Jersey’s personal injury statute of limitations is generally two years. However, for latent diseases that manifest years or decades after exposure, the discovery rule may toll the limitations period — meaning the clock may not start until you knew or reasonably should have known of your injury and its cause. For many Salem County residents, the connection between their drinking water and their health may only now be becoming apparent. The discovery rule is why a prompt legal evaluation is critical — but it is not a guarantee, and the specific deadline that applies to your situation must be confirmed by an attorney admitted in New Jersey.
What if I do not have cancer yet but I have been exposed?
You may still have a claim for medical monitoring. New Jersey courts have recognized medical monitoring as a recoverable remedy in toxic exposure cases, allowing exposed residents to recover the costs of periodic medical surveillance even without a present manifestation of disease. If you drank contaminated water for years, you need ongoing screening — kidney function tests, liver panels, blood counts, thyroid screening — and the company that contaminated your water should pay for that screening, not you.
Can I sue if I signed something from the company?
It depends on what you signed. If you signed a release, a settlement agreement, or a waiver, its scope and enforceability must be reviewed by qualified counsel. If you signed a document that was presented in a language you do not fully understand, or under pressure, or without a clear explanation of what rights you were giving up, there may be grounds to challenge it. Do not assume a signed form ends your rights until an attorney has reviewed it. And do not sign anything else from the company or its representatives without consulting counsel first.
How much is my PFAS case worth?
No attorney can tell you what your case is worth without reviewing your exposure history, medical records, and water source data. Individual medical monitoring claims may be valued in the six-figure range. Individual cancer cases can reach seven figures. Wrongful death claims can reach seven to eight figures. Property damage claims depend on the extent of contamination in your area and its impact on property values. Punitive damages may be warranted given the documented decades of unauthorized discharges. The aggregate value of a coordinated mass tort across tens of thousands of affected residents could reach nine figures. Past results depend on the facts of each case and do not guarantee future outcomes.
Is it too late if the contamination happened years ago?
Not necessarily. The discovery rule in New Jersey may toll the statute of limitations for latent injuries — diseases that manifest years or decades after exposure. For many residents, the connection between their health and the Chambers Works contamination is only now becoming apparent, with the government’s documentation of decades of discharges. The consent decree itself, with its finding of unauthorized discharges through 2020, is recent. But the discovery rule is not unlimited, and some states impose outer deadlines that can bar claims regardless of discovery. The only way to know if you are still within your rights is to have an attorney evaluate your specific timeline.
What about my property value?
PFAS contamination of the drinking water supply can diminish property values in the affected area. If the public knows your neighborhood’s water is contaminated — and with the consent decree and news coverage, the public does know — that knowledge affects what buyers are willing to pay. Property damage claims seek compensation for this diminished value, as well as the cost of water filtration systems and the loss of use of your contaminated water supply. These claims are typically proven through real estate appraisal methodology.
What should I do right now?
Document your exposure history (where you lived, your water source, the years), gather your medical records, do not sign anything from the company or its insurers, do not provide a recorded statement, and contact qualified toxic tort counsel for a free consultation. The consultation is free, confidential, and carries no obligation. The call is the first step — and in a case where evidence is aging and the statute of limitations is running, the first step is the one that matters most.
Why Attorney911: The Trial Team That Knows How the Other Side Works
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes New Jersey environmental contamination and toxic exposure cases, working with local counsel and pro hac vice admission where required. We do not have an office in New Jersey and we do not claim a New Jersey bar admission — but we take cases in this state because the fight is the same fight wherever a corporation has poisoned a community’s water, and we know how to wage it.
Ralph Manginello is our Managing Partner. He has been licensed for 27+ years, admitted to practice in Texas and before the U.S. District Court for the Southern District of Texas, including federal court. He was a journalist before he was a lawyer — he spent years learning how to find the story the powerful do not want told, and he brought that instinct into the courtroom. He hates losing. He approaches every case as a fight that will be won on preparation, evidence, and the willingness to take it to a jury. Read more about Ralph.
Lupe Peña is our associate attorney. Before he joined our side of the table, Lupe spent years inside a national insurance-defense firm — the rooms where adjusters and their software decide how to deny, delay, and devalue claims from people exactly like the residents of Salem County. He knows how the other side values claims, how they pick their medical experts, how they use surveillance and social media, and how they deploy delay tactics designed to push people into accepting less than their case is worth. Now he uses that knowledge for injured clients. And he conducts full client consultations in fluent Spanish, without an interpreter. Read more about Lupe.
We work on contingency. Our fee is 33.33% before trial and 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. We have live staff available 24 hours a day, 7 days a week — not an answering service, but people who can take your call and start the process. The number is 1-888-ATTY-911.
Hablamos Español. Lupe conducts full consultations in Spanish, and our bilingual staff is ready to serve your family in the language you are most comfortable speaking.
The contamination at Chambers Works is not an abstract legal problem. It is in the water your children drank. It is in the body of someone you love who got sick. It is in the property value of the home you have spent your life paying for. The companies that put it there are some of the largest chemical corporations in the world, with armies of lawyers whose job is to pay you as little as possible for what they did. You need your own army — people who know how the other side works because they have been on the other side, people who have spent decades in courtrooms, people who will tell you the truth about what your case is worth and then fight to get every dollar of it.
That is what we do. The call is free. The consultation is confidential. And the clock is running.
Call 1-888-ATTY-911. Or contact us through our website. We will talk to you in English or in Spanish, we will answer your questions, and we will tell you honestly whether you have a case and what to do next. Past results depend on the facts of each case and do not guarantee future outcomes — but the first step is always the same: pick up the phone and ask.